NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Tag: Alan Cassels

2 5/25/2017

The anatomy of a drug website: 5 pharma tactics to be wary of

3 5/23/2016

Inside the Sausage Factory of Drug Approval: Nuplazid (pimavanserin) coverage didn’t inspect closely enough

10 6/5/2015

Astroturfers rule the day: FDA’s flibanserin reviewers were “emotionally blackmailed” by a slick lobbying campaign

3 6/3/2015

Pink Viagra may be coming soon (but for teetotalers, only!)

2 2/5/2015

More Bow Tie, Less Glitz Please: Breast Cancer Vaccine Promises Don’t Serve Readers/Viewers

2 12/14/2012

New word of the week: 23andMe aims to valorize your spit

10/5/2012

Potpourri: What is AHA smoking? Will flu shots keep you healthy? Why do some oppose comparative effectiveness research?